ENGN
enGene Therapeutics Inc.
Next earnings Sep 9, 2026 · consensus $-0.51 EPS
Last earnings +9.3% on 2026-06-15
$1.76
▲ +2.92%$1.76▼ -46.50%
over 1Y
L $1.44EODHDH $12.17
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.9%
1W+0.6%
1M-0.6%
3M-75.2%
YTD-80.2%
1Y-46.8%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 19 analysts
Buy
Conservative balance sheet (liabilities/equity 0.32x).
The read
Sources: SEC EDGAR (CIK 0001980845, latest 10-Q filed 2026-06-15) · EODHD · as of 6/25/2026, 8:56:51 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.